![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] l‐Carnitine and heart disease](https://ars.els-cdn.com/content/image/1-s2.0-S1756464626001210-gr1.jpg)
l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] l‐Carnitine and heart disease
Description
The severity of graying correlates with the level of ROS
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://figures.semanticscholar.org/b5793411365f90c7a7e2d59ac224313ee4306590/3-Figure1-1.png)
Notably, in a CysDA model of PD, sulforaphane-mediated improvement in neuronal viability peaked at 0.1 M and had no benefit at 10 (Vauzour et al., 2010)
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0313-7/MediaObjects/41419_2018_313_Fig1_HTML.jpg)
44,Suppl 1 (2021): S15-S33
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://www.researchgate.net/publication/358930749/figure/fig2/AS:11431281387222762@1745101926623/The-Role-of-l-carnitine-in-fatty-acid-transport-and-b-oxidation-in-mitochondria-FACS_Q320.jpg)
doi: 10.1139/H07-078
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://theenergyblueprint.com/wp-content/uploads/2021/01/Screenshot-2021-05-24-at-21.46.57-1024x359.png)
doi: 10.1038/s41420-022-01205-z
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11154-018-9448-1/MediaObjects/11154_2018_9448_Fig1_HTML.png)
Vitamin C is a vital cofactor to the formation of collagen, the connective tissue which supports arterial walls, skin, bones, and teeth [10-12]
![l carnitine mitochondrial disease metabolic disorders and novel clinical approaches: Mechanistic insights from deficiency management to liver and kidney treatment PDF] lCarnitine and heart disease](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c1/8910660/5cf7424942e1/ijms-23-02717-g007.jpg)
